Author/Creator: Crawford, Jodie - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Crawford, Jodie

1. Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups. (February 2019)

Authors:: Bakerly, Nawar Diar; Woodcock, Ashley; Collier, Susan; Leather, David A.; New, John P.; Crawford, Jodie; Harvey, Catherine; Vestbo, Jørgen; Boucot, Isabelle
Journal:: Respiratory medicine
Issue:: Volume 147(2019)
Page Start:: 58
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability. Issue 2 (22nd February 2018)

Authors:: Woodcock, Ashley; Boucot, Isabelle; Leather, David A.; Crawford, Jodie; Collier, Susan; Bakerly, Nawar Diar; Hilton, Emma; Vestbo, Jørgen
Journal:: European respiratory journal
Issue:: Volume 51:Issue 2(2018)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study. (2nd September 2021)

Authors:: Nakamura, Yoichi; Hozawa, Soichiro; Sagara, Hironori; Ohbayashi, Hiroyuki; Lee, Laurie A.; Crawford, Jodie; Tamaoki, Jun; Nishi, Takanobu; Fowler, Andrew
Journal:: Current medical research and opinion
Issue:: Volume 37:Number 9(2021)
Page Start:: 1657
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: A randomized trial. Issue 1 (January 2015)

Authors:: Lin, Jiangtao; Kang, Jian; Lee, Sang Haak; Wang, Changzheng; Zhou, Xiangdong; Crawford, Jodie; Jacques, Loretta; Stone, Sally
Journal:: Respiratory medicine
Issue:: Volume 109:Issue 1(2015)
Page Start:: 44
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial. Issue 6 (25th February 2013)

Authors:: Busse, William W; O'Byrne, Paul M; Bleecker, Eugene R; Lötvall, Jan; Woodcock, Ashley; Andersen, Leslie; Hicks, Wesley; Crawford, Jodie; Jacques, Loretta; Apoux, Ludovic; Bateman, Eric D
Journal:: Thorax
Issue:: Volume 68:Issue 6(2013)
Page Start:: 513
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease. (March 2021)

Authors:: Bakerly, Nawar Diar; Browning, Dominy; Boucot, Isabelle; Crawford, Jodie; McCorkindale, Sheila; Stein, Norman; New, John P.
Journal:: Therapeutic advances in respiratory disease
Issue:: Volume 15(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗